Valbenazine is a selective vesicular monoamine transporter 2 (VMAT2) inhibitor used to treat tardive dyskinesia, a movement disorder caused by antipsychotic medications. It works by reducing dopamine release in the brain, thereby alleviating involuntary movements. Valbenazine is metabolized in the liver and has a half-life of 15 to 22 hours.
Cleanchem is a trusted provider of premium pharmaceutical reference materials, specializing in Valbenazine and its associated compounds. Our catalog includes pharmacopeial and non-pharmacopeial Valbenazine impurities, metabolites, nitrosamine derivatives (N-NO compounds), and stable isotope-labeled products. These reference standards play a critical role in pharmaceutical R&D, supporting activities such as product formulation, ANDA and DMF submissions, quality assurance, analytical method development, and stability assessments.
All Valbenazine-related substances undergo comprehensive characterization and are delivered with complete Certificates of Analysis and supporting analytical documentation to ensure regulatory adherence. Upon request, we can offer EP/USP traceable standards. Our products are routinely re-evaluated to maintain consistent quality and performance.
English
Arabic
Chinese (Simplified)
French
Japanese
Portuguese
Russian
Spanish
